首页> 美国卫生研究院文献>other >Polyester-Based Microdisc Systems for Sustained Release of Neuroprotective Phosphine-Borane Complexes
【2h】

Polyester-Based Microdisc Systems for Sustained Release of Neuroprotective Phosphine-Borane Complexes

机译:基于聚酯的微碟系统用于神经保护性膦-硼烷配合物的缓释

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Phosphine-borane complexes are recently developed redox-active drugs that are neuroprotective in models of optic nerve injury and radioprotective in endothelial cells. However, a single dose of these compounds is short-lived, necessitating development of sustained-release formulations of these novel molecules. We screened a library of biodegradable co- and non-block polyester polymer systems for release of incorporated phosphine-borane complexes to evaluate them as drug delivery systems for use in chronic disease. Bis(3-propionic acid methyl ester)phenylphosphine borane complex (PB1) was combined with biodegradable polymers based on poly(D,L-lactide) (PDLLA), poly(L-lactide) (PLLA), poly(caprolactone) (PCL), poly(lactide-co-glycide) (PLGA), or poly(dioxanone-co-caprolactone) (PDOCL) to make polymer microdiscs, and release over time quantified. Of 22 polymer-PB1 formulations tested, 17 formed rigid polymers. Rates of release differed significantly based on the chemical structure of the polymer. PB1 released from PLGA microdiscs released most slowly, with the most linear release in polymers of 60:40 LA:GA, acid endcap, Mn 15,000–25,000 and 75:25 LA:GA, acid endcap, Mn 45,000–55,000. Biodegradable polymer systems can therefore be used to produce sustained-release formulations for redox-active phosphine-borane complexes, with PLGA-based systems most suitable for very slow release. Sustained release could enable translation to a clinical neuroprotective strategy for chronic diseases such as glaucoma.
机译:膦-硼烷复合物是最近开发的氧化还原活性药物,在视神经损伤模型中具有神经保护作用,在内皮细胞中具有放射保护作用。但是,这些化合物的单剂量寿命很短,因此有必要开发这些新型分子的缓释制剂。我们筛选了可生物降解的共嵌段和非嵌段聚酯聚合物系统的文库,以释放掺入的膦-硼烷配合物,以将其评估为用于慢性疾病的药物递送系统。将双(3-丙酸甲酯)苯基膦硼烷络合物(PB1)与基于聚(D,L-丙交酯)(PDLLA),聚(L-丙交酯)(PLLA),聚(己内酯)(PCL)的可生物降解聚合物结合),聚(丙交酯-共-乙交酯)(PLGA)或聚(二恶烷酮-共-己内酯)(PDOCL)制成聚合物微盘,并随时间推移定量释放。在测试的22种聚合物-PB1配方中,有17种形成了刚性聚合物。基于聚合物的化学结构,释放速率有显着差异。从PLGA微盘释放的PB1释放速度最慢,在60:40 LA:GA,酸性端帽,Mn 15,000–25,000和75:25 LA:GA,酸性端帽,Mn 45,000–55,000的聚合物中,线性释放最多。因此,可生物降解的聚合物系统可用于生产氧化还原活性膦-硼烷配合物的缓释制剂,而基于PLGA的系统最适合非常缓慢的释放。缓释可以使对慢性疾病如青光眼的临床神经保护策略转变。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号